Literature DB >> 23576919

Liposclerosing myxofibrous tumor (LSMFT), a study of 33 patients: should it be a distinct entity?

Jonathan Dattilo1, Edward F McCarthy.   

Abstract

Liposclerosing myxoid fibrous tumor (LSMFT) is a recently described bone lesion site specific to the proximal femur. We have studied the radiographs and clinical features of 33 patients with this disorder. Histologic material was available for study in 18 of these patients. Histologic study revealed that 12 of these 18 had an underlying fibrous dysplasia and these had an underlying intraosseous lipoma. Because of this histologic evidence as well as the radiographic spectrum of the other lesions, we conclude that LSMFT is not a specific lesion and use of the term should be discontinued.

Entities:  

Mesh:

Year:  2012        PMID: 23576919      PMCID: PMC3565412     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  14 in total

Review 1.  Radiology as gross pathology in evaluating chondroid lesions.

Authors:  B D Ragsdale; D E Sweet; T N Vinh
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466

2.  Intraosseous lipomas with reactive ossification in the proximal femur. Report of eight cases.

Authors:  J W Milgram
Journal:  Skeletal Radiol       Date:  1981       Impact factor: 2.199

Review 3.  Fibromyxoma of bone: a case report and review of the literature.

Authors:  Jendrik Hardes; Stefanie Scheil-Bertram; Georg Gosheger; Michael Schulte
Journal:  Acta Orthop Belg       Date:  2006-01       Impact factor: 0.500

4.  Liposclerosing myxofibrous tumor: a radiologic-pathologic-distinct fibro-osseous lesion of bone with a marked predilection for the intertrochanteric region of the femur.

Authors:  M J Kransdorf; M D Murphey; D E Sweet
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

5.  Polymorphic fibro-osseous lesions of bone: an almost site-specific diagnostic problem of the proximal femur.

Authors:  B D Ragsdale
Journal:  Hum Pathol       Date:  1993-05       Impact factor: 3.466

6.  Activating Gs alpha mutation at the Arg201 codon in liposclerosing myxofibrous tumor.

Authors:  Atsushi Matsuba; Akira Ogose; Kunihiko Tokunaga; Hiroyuki Kawashima; Tetsuo Hotta; Sayuri Urakawa; Hajime Umezu; Takeshi Higuchi; Naoto Endo
Journal:  Hum Pathol       Date:  2003-11       Impact factor: 3.466

Review 7.  From the archives of the AFIP: benign musculoskeletal lipomatous lesions.

Authors:  Mark D Murphey; John F Carroll; Donald J Flemming; Thomas L Pope; Francis H Gannon; Mark J Kransdorf
Journal:  Radiographics       Date:  2004 Sep-Oct       Impact factor: 5.333

8.  Liposclerosing myxofibrous tumour: a traumatized variant of fibrous dysplasia? Report of four cases and review of the literature.

Authors:  J M Heim-Hall; R P Williams
Journal:  Histopathology       Date:  2004-10       Impact factor: 5.087

9.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

10.  Fibrous dysplasia with degenerative atypia: a benign lesion potentially mistaken for sarcoma.

Authors:  Franco Bertoni; Luis Fernando Arias; Marco Alberghini; Patrizia Bacchini
Journal:  Arch Pathol Lab Med       Date:  2004-07       Impact factor: 5.534

View more
  2 in total

Review 1.  Benign periarticular, bone and joint lipomatous lesions.

Authors:  Si Wei Kheok; Keh Oon Ong
Journal:  Singapore Med J       Date:  2017-09       Impact factor: 1.858

2.  Liposclerosing myxofibrous tumor: A series of 9 cases and review of the literature.

Authors:  Eduardo Rinaldi Regado; Pedro Braga Linhares Garcia; Anabela Cunha Caruso; Ana Luzia Brito de Almeida; Ierecê Lins Aymoré; Walter Meohas; Diego Pinheiro Aguiar
Journal:  J Orthop       Date:  2016-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.